Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

3(50.0%)

N/A

2(33.3%)

Early Phase 1

1(16.7%)

6Total

Phase 2(3)

N/A(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06936514Not ApplicableEnrolling By Invitation

Clinical Study on Deep Cervical Lymphatic Trunk Decompression Combined With Mid-Cervical Deep Lymph Node-External Jugular Vein Anastomosis for Alzheimer's Disease Treatment

Role: lead

NCT05396209Not ApplicableUnknown

To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes.

Role: lead

NCT03620552Early Phase 1Unknown

18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia

Role: lead

NCT03555292Phase 2Unknown

11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes

Role: lead

NCT02024373Phase 2Completed

Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma

Role: lead

NCT02192320Phase 2Unknown

The Clinical Study of Atorvastatin and Dexamethasone on Treatment for Chronic Subdural Hematoma in the Patients With Coagulation Disorders

Role: lead

All 6 trials loaded